Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1776-260X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy ; volume:15 ; number:1 ; day:25 ; month:1 ; year:2020 ; pages:101-113 ; date:2.2020
Targeted oncology ; 15, Heft 1 (25.1.2020), 101-113, 2.2020
- Urheber
-
Olbryt, Magdalena
Pigłowski, Wojciech
Rajczykowski, Marcin
Pfeifer, Aleksandra
Student, Sebastian
Fiszer-Kierzkowska, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-020-00695-0
- URN
-
urn:nbn:de:101:1-2020051422055710746901
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olbryt, Magdalena
- Pigłowski, Wojciech
- Rajczykowski, Marcin
- Pfeifer, Aleksandra
- Student, Sebastian
- Fiszer-Kierzkowska, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melanoma : Biologically Targeted Therapeutics
NF1 mutations in conjunctival melanoma
Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
Somatic mutations in primary melanoma tumors
Targeted Therapies for Melanoma Brain Metastases
Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
Lack of SF3B1 R625 mutations in cutaneous melanoma
Clinical significance of BRAF mutations in metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Somatic mutations in melanoma and non-melanoma skin cancers : exome sequence-based study
Melanoma : Biologically Targeted Therapeutics
NF1 mutations in conjunctival melanoma
Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
Somatic mutations in primary melanoma tumors
Targeted Therapies for Melanoma Brain Metastases
Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
Lack of SF3B1 R625 mutations in cutaneous melanoma
Clinical significance of BRAF mutations in metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations
Somatic mutations in melanoma and non-melanoma skin cancers : exome sequence-based study
Melanoma : Biologically Targeted Therapeutics
NF1 mutations in conjunctival melanoma
Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis
Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis
Somatic mutations in primary melanoma tumors
Targeted Therapies for Melanoma Brain Metastases
Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
Lack of SF3B1 R625 mutations in cutaneous melanoma
Clinical significance of BRAF mutations in metastatic melanoma
STAT3 – the switch of melanoma-associated NRAS mutations